← Leaderboards
Donald Bellgrau
University Of Colorado Denver
$4,610,601
Attributed
$4,610,601
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $357.6K · FY2006–16$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,610,601 · 6
By mechanism
P30$2,554,768 · 3
R01$1,291,052 · 1
R43$764,781 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Paul A Bunn$21,859,370
- Marian Elizabeth Betz$8,722,750
- John D Fluke$268,693
- Donald Ym Leung$75,548,590
- Ann Marie Hart$49,211
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsUniversitiesComprehensive Cancer CenterInterestResource SharingCancer CenterColoradoCancer Center Support GrantFlow CytometryTranslatingRecruitment ActivityApoptosisImmune SystemImmunotherapyImmunotherapeutic AgentInflammationAnimal TissueAffectCollaborationsBiomedical FacilityDiabetes MellitusImmunologicsCellular Biology
Grant awards (28)
IMMUNOLOGY-IMMUNOTHERAPY$254,052
P30 · FY2016 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$255,589
P30 · FY2015 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$249,641
P30 · FY2014 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$183,776
P30 · FY2013 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$963
P30 · FY2013 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$254,604
P30 · FY2012 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$23,024
P30 · FY2010 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$24,358
P30 · FY2009 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$22,910
P30 · FY2008 · CA · contact PI
Provoking anti-tumor immune responses with Fas ligand$335,358
R43 · FY2007 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$22,280
P30 · FY2007 · CA · contact PI
Provoking anti-tumor immune responses with Fas ligand$329,413
R43 · FY2006 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$12,359
P30 · FY2006 · CA · contact PI
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2004 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2003 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2002 · DK
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2002 · CA
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2002 · CA
CORE--CYTOMETRY FACILITY$0
P30 · FY2002 · DK
CORE--CYTOMETRY FACILITY$0
P30 · FY2002 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2001 · DK
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2001 · CA
CORE--CYTOMETRY FACILITY$250,000
P30 · FY2001 · DK
USE OF FAS LIGAND TO SUPPRESS ARTHRITIS$100,010
R43 · FY2001 · AI
IMMUNOLOGY AND IMMUNOTHERAPY$0
P30 · FY2001 · CA
CORE--CYTOMETRY FACILITY$0
P30 · FY2001 · DK
CORE--CYTOMETRY FACILITY$0
P30 · FY2001 · DK
CORE--CYTOMETRY FACILITY$250,000
P30 · FY2000 · DK